Publication

HOME > Publication > Publication 2016
Publication 2016
  1. Oshima K, Nakamura S, Iwanaga N, Takemoto K, Miyazaki T, Yanagihara K, Miyazaki Y, Mukae H, Kohno S, Izumikawa K. Efficacy of high-dose Meropenem (six grams per day) in treatment of experimental murine pneumonia induced by meropenem-resistant Pseudomonas aeruginosa.Antimicrob Agents Chemother. 61(1), e02056-16, 2016
  2. Kohno S, Tamura K, Niki Y, Izumikawa K, Oka S, Ogawa K, Kadota J, Kamei K, Kanda Y, Kiuchi T, Shibuya K, Takakura S, Takata T, Takesue Y, Teruya K, Tokimatsu I, Fukuda T, Maesaki S, Makimura K, Mikamo H, Mitsutake K, Miyazaki Y, Mori M, Yasuoka A, Yano K, Yamanaka N, Yoshida M. Executive summary of Japanese domestic guidelines for management of deep-seated mycosis 2014. Med Mycol J. 57(4):E117-E163, 2016
  3. Hanada M, Sakamoto N, Ishimatsu Y, Kakugawa T, Obase Y, Kozu R, Senjyu H, Izumikawa K, Mukae H, Kohno S: Effect of long-term treatment with corticosteroids on skeletal muscle strength, functional exercise capacity and health status in patients with interstitial lung disease. Respirology 21(6): 1088-1093, 2016
  4. Ashizawa N, Nakamura S, Ide S, Tashiro M, Takazono T, Imamura Y, Miyazaki T, Izumikawa K, Yamamoto Y, Yanagihara K, Miyazaki Y, Kohno S: Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal Agent. Intern Med 55(15): 2093-2099, 2016
  5. Harada T, Ishimatsu Y, Hara A, Morita T, Nakashima S, Kakugawa T, Sakamoto N, Kosai Y, Izumikawa K, Yanagihara K, Mukae H, Kohno S: Premedication with clarithromycin is effective against secondary bacterial pneumonia during influenza virus infection in a pulmonary emphysema mouse model. J Pharmacol Exp Ther 358(3): 457-463, 2016
  6. Tsuchiya T, Nakamura Y, Hayashi N, Matsumoto K, Miyazaki T, Nakatomi K, Fukuda M, Yamasaki T, Shimada M, Sano I, Taniguchi H, Tabata K, Fukuoka J, Yamasaki N, Nagayasu T, Tagawa T: A multicenter phase II study of concurrent chemoradiotherapy with cisplatin and oral S-1, followed by surgery for locally advanced non-small-cell lung cancer. Cancer Treatment Communications 7: 11-16, 2016
  7. Mizoguchi K, Nakamura Y, Sano K, Sato S, Ikegami Y, Motoshima K, Takemoto S, Ogawara D, Senju H, Sugasaki N, Ikeda T, Yamaguchi H, Nakatomi K, Fukuda M, Izumikawa K, Mukae H: Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations. Cancer Chemother Pharmacol 72(2): 377-382, 2016
  8. Nagayoshi Y, Yamamoto K, Hashimoto S, Hisatomi K, Doi S, Nagashima S, Kurohama H, Ito M, Takazono T, Nakamura S, Miyazaki T, Kohno S: An autopsy case of lepidic pulmonary metastasis from cholangiocarcinoma. Intern Med 55: 2849-2853, 2016
  9. Tashiro M, Fushimi K,Takazono T, Kurihara S, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Tashiro T, Kohno S, Izumikawa K: A mortality prediction rule for non-elderly patients with community-acquired pneumonia. BMC Pulm Med 16(1): 39-39, 2016
  10. Nishikawa H, Sakagami T, Yamada E, Fukuda Y, Hayakawa H, Nomura N, Mitsuyama J, Miyazaki T, Mukae H, Kohno S: T-2307, a Novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2. J Antimicrob Chemoth 71(7): 1845-1855, 2016
  11. Kurihara S, Satoh A, Yu F, Hayasaka D, Shimojima M, Tashiro M, Saijo T, Takazono T, Imamura Y, Miyazaki T, Tsukamoto M, Yanagihara K, Mukae H, Saijo M, Morita K, Kohno S, Izumikawa K: The world first two cases of severe fever with thrombocytopenia. syndrome: An epidemiological study in Nagasaki, Japan. J Infect Chemother 22(7): 461-465, 2016
  12. Nakamura S, Iwanaga N, Seki M, Fukudome K, Oshima K, Miyazaki T, Izumikawa K, Yanagihara K, Miyazaki Y, Mukae H, Kohno S: Toll-like receptor 4 agonistic antibody promotes host defence against chronic Pseudomonas aeruginosa lung infection in mice. Infect Immun 84(7): 1986-1993, 2016
  13. Nishikawa H, Miyazaki T, Nakayama H, Minematsu A, Yamaguchi S, Yamashita K, Takazono T, Shimamura S, Nakamura S, Izumikawa K, Yanagihara K,  Kohno S, Mukae H: Roles of vacuolar H+-ATPase in the oxidative stress response of Candida glabrata. FEMS Yeast Res 16(5): fow054, 2016
  14. Hirayama T, Takazono T, Horai Y, Tashiro M, Saijo T, Kosai K, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Izumikawa K, Yanagihara K, Kawakami A, Kohno S: Pulmonary Nocardiosis Caused by Nocardia concava with a Literature Review. Intern Med 55(9): 1213-1217, 2016
  15. Kaku N, Morinaga Y, Takeda K, Kosai K, Uno N, Hasegawa H, Miyazaki T, Izumikawa K, Mukae H, Yanagihara K: Antimicrobial and immunomodulatory effects of tedizolid against methicillin-resistant Staphylococcus aureus in a murine model of hematogenous pulmonary infection. Int J Med Microbiol 306(6): 421-428, 2016
  16. Takazono T, Sawai T, Tashiro M, Saijo T, Yamamoto K, Imamura Y, Miyazaki T, Suyama N, Izumikawa K, Kakeya H, Yanagihara K, Mukae H, Kohno S: Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment. Intern Med 55(19): 2877-2880, 2016
  17. Yoshida M, Takazono T, Tashiro M, Saijo T, Morinaga Y, Yamamoto K, Nakamura S, Imamura Y, Miyazaki T, Sawai T, Nishino T, Izumikawa K, Yanagihara K, Mukae H, Kohno S: Recurrent Streptococcus agalactiae toxic shock syndrome triggered by a tumor necrosis factor-α inhibitor. Intern Med 55(21): 3211-3214, 2016
  18. Ashizawa N, Tsuji Y, Kawago K, Higashi Y, Tashiro M, Nogami M, Gejo R, Narukawa M, Kimura T, Yamamoto Y: Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis with combination therapy using linezolid and rifampicin under therapeutic drug monitoring. J Infect Chemother 22(5): 331-4, 2016
  19. Abe S, Obata Y, Oka S, Koji T, Nishino T, Izumikawa K: Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation. Med Mol Morphol 49(3): 144-53, 2016
  20. Ogawa Y, Sato M, Tashiro M, Miyazaki M, Nagata K, Takahashi N, Kasahara K, Izumikawa K, Yano H, Mikasa K: Rapid development of a mycotic aneurysm of the intracranial artery secondary to Scedosporium apiospermum sinusitis. Med Mycol Case Rep 14: 30–32, 2016
  21. Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, Tashiro M, Saijo T, Kosai K, Morinaga Y, Nakamura S, Kurihara S, Tsukamoto M, Miyazaki T, Tashiro T, Kohno S, Yanagihara K, Izumikawa K. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients co-infected with nontuberculous mycobacteria. Med Mycol. 54(2): 120-7, 2016
  22. Izumikawa K. Clinical features of severe or fatal Mycoplasma pneumoniae pneumonia. Front Microbiol. 7:800, 2016
  23. Izumikawa K. Recent advances in chronic pulmonary aspergillosis. Respir Investig. 54(2):85-91, 2016